Welcure Drugs & Pharmaceuticals (BOM:524661) PEG Ratio: N/A (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524661 Welcure Drugs & Pharmaceuticals Ltd BOM:524661
20 GF Score
Price ₹0.22
! 5 Warning Signs
View Full Analysis

What is Welcure Drugs & Pharmaceuticals PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Welcure Drugs & Pharmaceuticals's PE Ratio without NRI is 0.00. Welcure Drugs & Pharmaceuticals's 5-Year EBITDA growth rate is 0.00%. Therefore, Welcure Drugs & Pharmaceuticals's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Welcure Drugs & Pharmaceuticals's PEG Ratio or its related term are showing as below:



BOM:524661's PEG Ratio is not ranked *
in the Medical Distribution industry.
Industry Median: 2.01
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Welcure Drugs & Pharmaceuticals  (BOM:524661) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Welcure Drugs & Pharmaceuticals PEG Ratio Related Terms


Welcure Drugs & Pharmaceuticals PEG Ratio Historical Data

* Premium members only.

The historical data trend for Welcure Drugs & Pharmaceuticals's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Welcure Drugs & Pharmaceuticals PEG Ratio Chart

Welcure Drugs & Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Welcure Drugs & Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:524661 vs MCK, COR, CAH: PEG Ratio Comparison

For the Medical Distribution subindustry, Welcure Drugs & Pharmaceuticals's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Welcure Drugs & Pharmaceuticals PEG Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Welcure Drugs & Pharmaceuticals's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Welcure Drugs & Pharmaceuticals's PEG Ratio falls into.


BOM:524661
20GF Score
Welcure Drugs & Pharmaceuticals Ltd BOM:524661
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Welcure Drugs & Pharmaceuticals PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Welcure Drugs & Pharmaceuticals's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Welcure Drugs & Pharmaceuticals Business Description

Address Laxmi Nagar, Plot No. 55, Office No. 104, First Floor, Vijay Block, Delhi East, Delhi, Delhi, IND, 110092
Welcure Drugs & Pharmaceuticals Ltd is a pharmaceutical company. The company operates exclusively in a single business segment: the trading of medical products. The company's revenue is entirely derived from this segment, encompassing a range of activities from sourcing pharmaceutical products to facilitating their distribution in domestic and international markets.
20GF Score

Get the complete analysis for BOM:524661

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.22
Price